Novel trypanosome receptor for thrombospondin-1
血小板反应蛋白-1 的新型锥虫受体
基本信息
- 批准号:8013618
- 负责人:
- 金额:$ 14.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinity ChromatographyAmino AcidsApplications GrantsAreaAwardBindingBiologyBloodCardiacCardiovascular PathologyCell CommunicationCellsChagas DiseaseChronicDNADataDevelopmentDiseaseEtiologyExcisionExtracellular MatrixExtracellular Matrix ProteinsFacultyFundingGene ExpressionGenesGoalsGrantHealthHeartHeart DiseasesIndividualInfectionInfection preventionInternationalInterventionInvestigationJournalsKnowledgeLaboratoriesLeadLinkMALDI-TOF Mass SpectrometryMinorityModelingMolecularMolecular ProfilingMolecular TargetMorbidity - disease rateMusMyocardial InfarctionOligosaccharidesParasitesPathogenesisPathologyPlayPositioning AttributePostdoctoral FellowProcessProteinsPublic HealthPublicationsPublishingRNA InterferenceReceptor CellRecombinant ProteinsResearchResearch PersonnelRoleScienceScientistSecureSeriesStagingSurfaceTHBS1 geneTestingThrombospondin 1TissuesTrainingTrypanosomaTrypanosoma cruziUniversitiesWild Type MouseWisconsinWorkbasegraduate studentheart cellin vivoinhibitor/antagonistinnovationinterestmedical schoolsmeetingsmicrobialmortalitymouse modelnovelnovel strategiespathogenpreventprogramsreceptorreceptor bindingresearch studysugar
项目摘要
DESCRIPTION (provided by applicant): Trypanosoma cruzi, the causative agent of Chagas' heart disease affects several million individuals causing significant morbidity and mortality, yet it remains incurable. T. cruzi modulates the gene expression profiles of a few extracellular matrix proteins to facilitate infection. One of the genes up-regulated early during infection by the parasite is host thrombospondin-1 (TSP-1), a matricellular protein. TSP-1 binds specifically to the surface of invasive forms of T. cruzi trypomastigotes and knockdown of host TSP-1 by RNA interference causes significant inhibition of T. cruzi infection. We hypothesize that the trypomastigote form of T. cruzi up- regulates host TSP-1 that interacts with trypanosome surface receptor(s) to enhance the infection of heart cells. The long-term goal of this research is to understand the molecular mechanisms that allow T. cruzi to infect heart cells, so that specific molecular intervention strategies can be developed to prevent infection of heart cells. The hypothesis will be tested by experiments based on these specific aims: 1. To clone and characterize the novel T. cruzi TSP-1 binding molecule. We will use affinity chromatography, MALDITOF-MS, PCR and purification of recombinant proteins approaches to identify, clone and characterize the trypomastigote receptor that is important in the process of T. cruzi infection; 2. To determine the in vivo role of TSP-1 gene in the process of T. cruzi infection using TSP-1 KO mice model. PUBLIC HEALTH RELEVANCE: In this project, we propose to identify and characterize a novel receptor on the surface of infectious T. cruzi trypomastigotes that binds specifically with host thrombospondin-1. This research is significant to public health because it will provide a molecular understanding of one of the first steps of infection of heart cells by infectious trypomastigotes, which will facilitate the development of specific molecular intervention strategies to prevent Chagas' heart disease.
描述(由申请人提供):Cruzi锥虫,Chagas心脏病的病因影响数百万个个体,导致了显着的发病率和死亡率,但仍然无法治愈。 T. Cruzi调节一些细胞外基质蛋白的基因表达谱,以促进感染。寄生虫在感染早期上调的基因之一是宿主血小板蛋白-1(TSP-1),一种母细胞蛋白。 TSP-1特异性结合了Cruzi锥虫的浸润性形式的表面和通过RNA干扰对宿主TSP-1的敲低,会引起对Cruzi T. cruzi感染的显着抑制。我们假设Cruzi上的锥虫形式调节与锥虫表面受体相互作用的宿主TSP-1,以增强心脏细胞的感染。这项研究的长期目标是了解允许克鲁齐(T. cruzi)感染心脏细胞的分子机制,以便可以开发特定的分子干预策略以防止心脏细胞感染。该假设将通过基于这些特定目的的实验测试:1。克隆和表征新型T. cruzi TSP-1结合分子。我们将使用亲和色谱,Malditof-MS,PCR和重组蛋白方法的纯化来识别,克隆和表征在T. Cruzi感染过程中很重要的锥虫受体。 2。使用TSP-1 KO小鼠模型确定TSP-1基因在T. Cruzi感染过程中的体内作用。公共卫生相关性:在这个项目中,我们建议在传染性的T. cruzi锥虫表面识别和表征一种新型受体,该受体与宿主血栓形成蛋白-1专门结合。这项研究对公共卫生而言是重要的,因为它将通过传染性锥虫对心脏细胞感染的第一步之一提供分子理解,这将有助于制定特定的分子干预策略,以防止Chagas的心脏病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pius N Nde其他文献
Pius N Nde的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pius N Nde', 18)}}的其他基金
Molecular mechanisms of Trypanosoma cruzi cardiopathogenesis
克氏锥虫心脏病发病的分子机制
- 批准号:
9269509 - 财政年份:2016
- 资助金额:
$ 14.36万 - 项目类别:
Molecular mechanisms of Trypanosoma cruzi cardiopathogenesis
克氏锥虫心脏病发病的分子机制
- 批准号:
9073494 - 财政年份:2016
- 资助金额:
$ 14.36万 - 项目类别:
Novel trypanosome receptor for thrombospondin-1
血小板反应蛋白-1 的新型锥虫受体
- 批准号:
7760539 - 财政年份:2009
- 资助金额:
$ 14.36万 - 项目类别:
Novel trypanosome receptor for thrombospondin-1
血小板反应蛋白-1 的新型锥虫受体
- 批准号:
7560303 - 财政年份:2009
- 资助金额:
$ 14.36万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 14.36万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 14.36万 - 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
- 批准号:
10588384 - 财政年份:2023
- 资助金额:
$ 14.36万 - 项目类别:
Defining the molecular interactions required for flavivirus genome packaging and virus assembly
定义黄病毒基因组包装和病毒组装所需的分子相互作用
- 批准号:
10750591 - 财政年份:2023
- 资助金额:
$ 14.36万 - 项目类别:
Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
通过综合应激反应针对甲基乙二醛诱发的糖尿病神经性疼痛
- 批准号:
10567294 - 财政年份:2023
- 资助金额:
$ 14.36万 - 项目类别: